TGM2 and cranioectodermal dysplasia: While at the time of inclusion into our study, all CeD patients were in clinical remission on a gluten-free diet for many years, few CeD patients had detectable levels of tissue transglutaminase antibodies (anti-tTG), which were significantly increased compared to the control group (Figure 1A).